REG - PureTech Health PLC - Transaction in Own Shares
05/02/2024 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240205:nRSE9356Ba&default-theme=true
RNS Number : 9356B PureTech Health PLC 05 February 2024
5 February 2024
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 2 February 2024
Number of ordinary shares purchased: 61,102
Highest price paid per share: 194.40p
Lowest price paid per share: 189.40p
Volume weighted average price paid per share: 191.32p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 19,349,968 ordinary
shares in treasury and has 270,118,191 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 270,118,191 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
02/02/2024 08:02:36 239 193 AQXE 00388296125TRLO0.1.1
02/02/2024 08:22:34 235 194 XLON 00388300424TRLO0.1.1
02/02/2024 08:22:34 143 194 XLON 00388300425TRLO0.1.1
02/02/2024 08:22:34 637 194 XLON 00388300426TRLO0.1.1
02/02/2024 08:22:34 27 194 XLON 00388300427TRLO0.1.1
02/02/2024 08:22:34 1042 194 XLON 00388300428TRLO0.1.1
02/02/2024 08:23:21 100 193.8 XLON 00388300606TRLO0.1.1
02/02/2024 08:23:21 421 193.8 XLON 00388300607TRLO0.1.1
02/02/2024 09:00:04 139 194.4 BATE 00388305563TRLO0.1.1
02/02/2024 09:10:33 1 194.4 BATE 00388307285TRLO0.1.1
02/02/2024 09:10:33 395 194.4 BATE 00388307286TRLO0.1.1
02/02/2024 09:11:11 239 193.4 AQXE 00388307364TRLO0.1.1
02/02/2024 09:11:11 114 193.2 CHIX 00388307365TRLO0.1.1
02/02/2024 09:11:11 78 193.2 CHIX 00388307366TRLO0.1.1
02/02/2024 09:11:11 329 193.2 CHIX 00388307367TRLO0.1.1
02/02/2024 09:11:11 918 193.4 XLON 00388307368TRLO0.1.1
02/02/2024 09:11:11 1166 193.4 XLON 00388307369TRLO0.1.1
02/02/2024 09:21:40 118 193.6 TRQX 00388309042TRLO0.1.1
02/02/2024 09:39:33 3 192.6 XLON 00388311542TRLO0.1.1
02/02/2024 09:39:33 390 192.6 BATE 00388311544TRLO0.1.1
02/02/2024 09:39:33 117 192.6 BATE 00388311543TRLO0.1.1
02/02/2024 09:39:33 120 192.6 CHIX 00388311545TRLO0.1.1
02/02/2024 09:39:33 401 192.6 CHIX 00388311546TRLO0.1.1
02/02/2024 09:39:33 2081 192.6 XLON 00388311547TRLO0.1.1
02/02/2024 09:39:33 118 192.6 TRQX 00388311548TRLO0.1.1
02/02/2024 11:11:43 59 192.8 XLON 00388323495TRLO0.1.1
02/02/2024 11:27:59 142 192.4 TRQX 00388325981TRLO0.1.1
02/02/2024 11:27:59 94 192.4 TRQX 00388325982TRLO0.1.1
02/02/2024 11:28:00 181 192.8 XLON 00388325983TRLO0.1.1
02/02/2024 11:28:05 32 192.8 XLON 00388326012TRLO0.1.1
02/02/2024 12:37:02 604 192.8 CHIX 00388336278TRLO0.1.1
02/02/2024 12:40:54 38 193 XLON 00388337012TRLO0.1.1
02/02/2024 13:23:28 38 193.2 XLON 00388343412TRLO0.1.1
02/02/2024 13:28:24 239 193 AQXE 00388344182TRLO0.1.1
02/02/2024 13:28:24 521 193 CHIX 00388344183TRLO0.1.1
02/02/2024 13:28:24 521 193 BATE 00388344184TRLO0.1.1
02/02/2024 13:28:25 253 193.2 XLON 00388344185TRLO0.1.1
02/02/2024 13:28:31 224 193.2 XLON 00388344190TRLO0.1.1
02/02/2024 13:30:18 1700 192.6 XLON 00388344813TRLO0.1.1
02/02/2024 13:30:18 384 192.6 XLON 00388344814TRLO0.1.1
02/02/2024 13:30:34 768 193 CHIX 00388345053TRLO0.1.1
02/02/2024 13:30:37 1071 193 XLON 00388345201TRLO0.1.1
02/02/2024 13:30:40 190 193 XLON 00388345226TRLO0.1.1
02/02/2024 13:38:38 205 192.2 AQXE 00388347486TRLO0.1.1
02/02/2024 13:38:38 34 192.2 AQXE 00388347487TRLO0.1.1
02/02/2024 13:38:38 132 192.4 TRQX 00388347488TRLO0.1.1
02/02/2024 13:38:38 2084 192.2 XLON 00388347489TRLO0.1.1
02/02/2024 13:38:38 413 192 BATE 00388347490TRLO0.1.1
02/02/2024 13:38:38 521 192 CHIX 00388347491TRLO0.1.1
02/02/2024 13:38:38 305 192 CHIX 00388347492TRLO0.1.1
02/02/2024 13:38:38 47 192 BATE 00388347493TRLO0.1.1
02/02/2024 13:38:38 216 192 CHIX 00388347494TRLO0.1.1
02/02/2024 13:38:38 61 192 BATE 00388347495TRLO0.1.1
02/02/2024 13:39:05 521 191.4 BATE 00388347582TRLO0.1.1
02/02/2024 13:39:07 100 191.4 XLON 00388347587TRLO0.1.1
02/02/2024 13:57:44 163 191 AQXE 00388352646TRLO0.1.1
02/02/2024 13:57:44 76 191 AQXE 00388352647TRLO0.1.1
02/02/2024 13:57:44 1563 191 XLON 00388352648TRLO0.1.1
02/02/2024 13:57:44 294 191 XLON 00388352649TRLO0.1.1
02/02/2024 13:57:44 735 191 XLON 00388352650TRLO0.1.1
02/02/2024 13:57:44 60 191 XLON 00388352651TRLO0.1.1
02/02/2024 14:00:19 1 191 XLON 00388353382TRLO0.1.1
02/02/2024 14:09:44 288 191.4 XLON 00388355697TRLO0.1.1
02/02/2024 14:09:44 158 191.4 XLON 00388355696TRLO0.1.1
02/02/2024 14:17:04 626 191.4 XLON 00388357470TRLO0.1.1
02/02/2024 14:17:04 371 191.4 XLON 00388357471TRLO0.1.1
02/02/2024 14:17:04 642 191.4 XLON 00388357472TRLO0.1.1
02/02/2024 14:36:14 239 191 AQXE 00388369123TRLO0.1.1
02/02/2024 14:36:14 239 191 AQXE 00388369124TRLO0.1.1
02/02/2024 14:36:14 138 191 BATE 00388369125TRLO0.1.1
02/02/2024 14:36:14 383 191 BATE 00388369126TRLO0.1.1
02/02/2024 14:36:14 132 191 CHIX 00388369127TRLO0.1.1
02/02/2024 14:36:14 200 191 CHIX 00388369129TRLO0.1.1
02/02/2024 14:36:14 380 191 CHIX 00388369128TRLO0.1.1
02/02/2024 14:36:14 2605 191 XLON 00388369130TRLO0.1.1
02/02/2024 14:36:14 870 191 XLON 00388369131TRLO0.1.1
02/02/2024 14:36:14 429 191 XLON 00388369132TRLO0.1.1
02/02/2024 14:41:22 66 190.6 TRQX 00388372860TRLO0.1.1
02/02/2024 14:41:22 2605 190.6 XLON 00388372861TRLO0.1.1
02/02/2024 14:41:22 38 190.6 TRQX 00388372862TRLO0.1.1
02/02/2024 14:41:22 114 190.6 TRQX 00388372863TRLO0.1.1
02/02/2024 14:41:22 86 190.6 TRQX 00388372864TRLO0.1.1
02/02/2024 14:44:14 521 191 BATE 00388374733TRLO0.1.1
02/02/2024 14:44:16 939 191 XLON 00388374748TRLO0.1.1
02/02/2024 14:53:23 521 190.4 CHIX 00388380451TRLO0.1.1
02/02/2024 14:53:23 521 190 BATE 00388380452TRLO0.1.1
02/02/2024 14:53:23 521 190 BATE 00388380453TRLO0.1.1
02/02/2024 14:53:23 1416 190.2 XLON 00388380455TRLO0.1.1
02/02/2024 14:56:48 290 190.2 XLON 00388382608TRLO0.1.1
02/02/2024 14:56:48 94 190.2 XLON 00388382609TRLO0.1.1
02/02/2024 15:01:15 526 190.2 XLON 00388385215TRLO0.1.1
02/02/2024 15:01:15 537 190.2 XLON 00388385216TRLO0.1.1
02/02/2024 15:01:41 537 190.2 XLON 00388385386TRLO0.1.1
02/02/2024 15:02:45 198 189.6 AQXE 00388386147TRLO0.1.1
02/02/2024 15:02:45 41 189.6 AQXE 00388386148TRLO0.1.1
02/02/2024 15:02:50 186 189.6 XLON 00388386186TRLO0.1.1
02/02/2024 15:06:28 380 189.4 XLON 00388388263TRLO0.1.1
02/02/2024 15:06:28 260 189.6 XLON 00388388264TRLO0.1.1
02/02/2024 15:06:33 279 189.6 XLON 00388388292TRLO0.1.1
02/02/2024 15:06:39 3323 189.6 XLON 00388388364TRLO0.1.1
02/02/2024 15:25:10 261 189.8 XLON 00388400156TRLO0.1.1
02/02/2024 15:25:10 741 189.8 XLON 00388400157TRLO0.1.1
02/02/2024 15:33:41 177 190.2 XLON 00388404210TRLO0.1.1
02/02/2024 15:48:03 239 190.2 AQXE 00388410294TRLO0.1.1
02/02/2024 15:48:03 246 190.2 CHIX 00388410295TRLO0.1.1
02/02/2024 15:48:03 87 190.2 CHIX 00388410297TRLO0.1.1
02/02/2024 15:48:03 275 190.2 CHIX 00388410296TRLO0.1.1
02/02/2024 15:48:03 41 190.2 TRQX 00388410298TRLO0.1.1
02/02/2024 15:48:03 77 190.2 TRQX 00388410299TRLO0.1.1
02/02/2024 15:48:03 1200 190.2 XLON 00388410300TRLO0.1.1
02/02/2024 15:48:03 72 190.2 TRQX 00388410301TRLO0.1.1
02/02/2024 15:48:03 1405 190.2 XLON 00388410302TRLO0.1.1
02/02/2024 15:59:43 154 190.6 XLON 00388416661TRLO0.1.1
02/02/2024 16:08:13 107 190.6 AQXE 00388421159TRLO0.1.1
02/02/2024 16:08:13 119 190.6 BATE 00388421160TRLO0.1.1
02/02/2024 16:08:13 101 190.6 XLON 00388421161TRLO0.1.1
02/02/2024 16:08:13 298 190.6 XLON 00388421162TRLO0.1.1
02/02/2024 16:08:16 489 190.6 XLON 00388421202TRLO0.1.1
02/02/2024 16:08:44 132 190.6 AQXE 00388421347TRLO0.1.1
02/02/2024 16:08:44 241 190.6 BATE 00388421348TRLO0.1.1
02/02/2024 16:16:35 6 190.6 AQXE 00388426174TRLO0.1.1
02/02/2024 16:16:35 161 190.6 BATE 00388426175TRLO0.1.1
02/02/2024 16:16:35 521 190.6 CHIX 00388426176TRLO0.1.1
02/02/2024 16:16:35 445 190.6 BATE 00388426177TRLO0.1.1
02/02/2024 16:16:35 1563 190.6 XLON 00388426178TRLO0.1.1
02/02/2024 16:16:35 1042 190.6 XLON 00388426179TRLO0.1.1
02/02/2024 16:20:51 1162 190.6 XLON 00388430065TRLO0.1.1
02/02/2024 16:21:16 989 190.6 XLON 00388430417TRLO0.1.1
02/02/2024 16:21:39 746 190.2 CHIX 00388430658TRLO0.1.1
02/02/2024 16:21:39 1338 190.2 XLON 00388430659TRLO0.1.1
02/02/2024 16:21:39 57 190.2 XLON 00388430660TRLO0.1.1
02/02/2024 16:21:39 665 190.2 XLON 00388430662TRLO0.1.1
02/02/2024 16:29:05 3 190.4 XLON 00388436051TRLO0.1.1
02/02/2024 16:29:36 82 190.6 TRQX 00388436518TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFVTFVIFIISRecent news on Puretech Health
See all newsREG - PureTech Health PLC - Total Voting Rights
AnnouncementREG - PureTech Health PLC - Final Results
AnnouncementREG - PureTech Health PLC - Notice of Results
AnnouncementRCS - PureTech Health PLC - PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
AnnouncementRCS - PureTech Health PLC - FDA Grants PRTC's LYT-200 Fast Track Designation
Announcement